A	B	C
1	Main
2		Brand Name	INCB24360
3		Indication	Solid tumors
4		Mechanism	Indoleamine 2, 3-dioxygenase (IDO)
5		Administration	Oral
6		Economics	INCY
7		IP
8
9		Clinical Trials
10			Phase 1/2, n = 50
11			Dose escalation.
12			Data expected mid 2012.